Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CHRONO - Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer

NCT03579394 is registered in ClinicalTrials.gov with ARCAGY/ GINECO GROUP as lead sponsor.

NCT NCT03579394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03579394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CHRONO - Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer
Lead sponsor
ARCAGY/ GINECO GROUP
Phase
Not applicable
Overall status
Completed
Start date
October 19, 2018
Completion date
October 17, 2025
Enrollment
211 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer stage iiib, ovarian cancer stage iiic, ovarian cancer stage iv